Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer

BACKGROUND: Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23–31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Currently, there is no standard treatment for patients with MB...

Descripción completa

Detalles Bibliográficos
Autores principales: Fumet, Jean-David, Wickre, Mark, Jacquot, Jean-Philippe, Bizollon, Marie-Helene, Melis, Adrien, Vanoli, André, Viel, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102904/
https://www.ncbi.nlm.nih.gov/pubmed/30126360
http://dx.doi.org/10.1186/s12885-018-4725-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102904/
https://www.ncbi.nlm.nih.gov/pubmed/30126360
http://dx.doi.org/10.1186/s12885-018-4725-7

Ejemplares similares